Outage notice:
Due to the global information outage that occurred this morning, Athena is taking swift action to respond, recover and restore our operations. We appreciate your patience as we work toward returning to normal operations.
| Test Code | Test Name | U.S. Patent No. |
| 871 | BBS1 (BBS) DNA Sequencing Test | 6,962,788 |
| 872 | BBS2 (BBS) DNA Sequencing Test | 7,008,782, 6,962,788 |
| 827 | ABCC8 (CH) DNA Sequencing Test | 6,054,313 |
| 876 | ABCC8 (NDM) DNA Sequencing Test | 6,054,313 |
| 483 | AChR/MuSK Reflexive Antibody Test | 7,267,820, 7,732,147 |
| 179 | ADmark® Early Onset Alzheimer's Evaluation | 6,117,978 6,194,153, 6,531,586 6,210,919, 6,998,467, 6,485,911, 5,840,540, 5,986,054, 7,846,679, 7,838,247 |
| 167 | ADmark® PS-1 DNA Sequencing Test | 6,194,153, 6,210,919, 6,531,586, 6,998,467 |
| 169 | ADmark® PS-2 DNA Sequencing Test | 6,485,911, 6,117,978, 5,840,540, 7,838,247 |
| 178 | ADmark® Alzheimer's Evaluation | 5,843,779, 5,861,257 6,010,913 6,114,133 |
| 177 | ADmark® Phospho-Tau/Total-Tau/Ab42 CSF Analysis & Interpretation (Symptomatic) | 5,843,779, 5,861,257, 6,010,913, 6,114,133 |
| 493 | Aprataxin DNA Sequencing Test | 7,119,186, 7,824,860 |
| 352 | Ataxia-Telangiectasia (ATM) DNA Deletion Analysis | 5,955,279, 6,951,724, 6,458,536 |
| 351 | Ataxia-Telangiectasia (ATM) DNA Sequencing Analysis | 5,955,279, 6,951,724, 6,458,536 |
| 531 | Atlastin (SPG3A) DNA Sequencing Test | 7,649,088, 7,108,975, 7,582,425 |
| 812 | Autoimmune Polyglandular Syndrome (AIRE) Evaluation | 7,217,806, 7,785,789 |
| 697 | Autosomal Dominant Ataxia Evaluation | 5,741,645, 5,840,491, 5,853,995, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,673,535, 6,844,431, 6,855,497, 7,118,893, 7,329,487, 7,585,629, 7,655,401, 7,741,458, 8,247,173, 8,748,096, 8,975,018, 8,163,483 |
| 653 | Autosomal Dominant Hereditary Spastic Paraplegia Evaluation | 6,924,126, 7,108,975, 7,582,425, 7,811,762, 7,649,088 |
| 693 | Autosomal Recessive Ataxia Evaluation | 7,824,860, 7,119,186 |
| 887 | Bardet-Biedl Syndrome Evaluation | 7,008,782, 6,962,788, 7,947,479, 8,129,161 |
| 837 | CEL (MODY8) Mutation Analysis | 5,827,683 |
| 277 | Co-GM1 Quattro™ | 5,989,829, 5,985,578, 6,077,681, 6,824,999, 6,020,140 |
| 861 | COL1A1 (OI) DNA Sequencing Test | 6,265,157 |
| 696 | Complete Ataxia Evaluation | 5,741,645, 5,840,491, 5,853,995, 6,150,091, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,844,431, 6,673,535, 6,855,497, 7,118,893, 7,119,186, 7,329,487, 7,527,931, 7,585,629, 7,655,401, 7,824,860, 8,163,483 |
| 353 | Complete Ataxia-Telangiectasia (ATM) Evaluation | 5,955,279, 6,951,724 |
| 286 | Complete Dejerine Sottas Neuropathy | 5,786,927, 727,698, 7,537,899 |
| 655 | Complete Hereditary Spastic Paraplegia Evaluation | 6,924,126, 7,108,975, 7,582,425, 7,811,762 |
| 243 | Complete HNPP Evaluation | 5,780,223, 5,599,920, 5,306,616 |
| 147 | Complete Myotonia Evaluation | 5,955,265, 5,977,333, 6,902,896, 7,442,782 |
| 126 | Complete Myotonic Dystrophy Evaluation | 5,955,265, 5,977,333 |
| 761 | Complete PKD Evaluation | 6,228,591, 6,031,088, 7,294,465, 7,553,644, 6,916,619, 7,521,190, 7,273,701, 7,083,915, 8,530,161 |
| 153 | Complete Rett Syndrome Evaluation | 6,709,817, 7,670,773, 8,637,236 |
| 573 | Complete SCN1A Evaluation | 7,078,515 |
| 215 | Complete SMA Evaluation (Reflexive) | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
| 556 | Complete Tuberous Sclerosis Evaluation | 6,326,483, 6,232,452, 6,548,258 |
| 819 | Congenital Hyperinsulinism Evaluation | 6,054,313, 5,723,593 |
| 245 | Congenital Hypomyelination Evaluation | 5,876,927 |
| 329 | Connexin Related Deafness Evaluation | 5,998,147, 6,485,908, 7,258,975, 8,455,195, 8,143,000 |
| 133 | Connexin32 DNA Sequencing Test | 5,691,144, 6,001,576 |
 |
||
| 143 | Connexin32 Evaluation | 5,691,144, 6,001,576 |
|
||
| 674 | CSTB (EPM1) Evaluation | 6,432,635 |
|
||
| 321 | Cx26 DNA Sequencing Test | 5,998,147, 6,485,908, 7,258,975, 8,455,195, 8,143,000 |
|
||
| 108 | DM1 DNA Test | 5,955,265, 5,977,333 |
|
||
| 110 | DM2 DNA Test | 6,902,896, 7,442,782 |
|
||
| 561 | Dysferlin Protein Blood Test | 7,172,858 |
|
||
| 626 | Dystonia (DYT1) DNA Test | 6,387,616, 6,921,814 |
|
||
| 207 | Early Onset Myotonia Evaluation | 5,955,265, 5,977,333 |
|
||
| 722 | Early Onset Nephrotic Syndrome Evaluation | 7,105,291, 6,207,811, 6,924,110, 7,388,086, 7,799,529 |
|
||
| 881 | Endocrine Hypertension (HSD11B2) Evaluation | 5,883,240, 5,780,223 |
|
||
| 296 | Entrapment Neuropathy Evaluation | 5,780,223 |
|
||
| 187 | Familial Hemiplegic Migraine Type I (CACNA1A) DNA Test | 5,714,319 |
|
||
| 119 | Friedreich Ataxia DNA Test | 6,150,091 |
|
||
| 348 | Friedreich's Ataxia DNA Sequencing Analysis | 6,150,091 |
|
||
| 349 | Friedreich's Ataxia Profile | 6,150,091 |
|
||
| 770 | Hereditary Interstitial Kidney Disease Assay | 7,781,164, 8,759,001 |
|
||
| 802 | HNF4A (MODY1) DNA Sequencing and Deletion Test | 6,187,533 |
|
||
| 717 | Inherited Focal and Segmental Glomerulosclerosis (FSGS) Evaluation | 6,924,110, 7,388,086, 7,745,597 |
|
||
| 874 | Lipoid CAH (StAR) Evaluation | 5,807,678, 5,872,230 |
|
||
| 222 | LITAF/SIMPLE DNA Sequencing Test | 7,449,291 |
|
||
| 811 | LRP5 (OPPG) DNA Sequencing Test | 6,545,137, 6,555,654, 7,244,577 |
|
||
| 821 | LRP5 Idiopathic Osteoporosis (IOP) DNA Sequencing Test | 6,545,137, 6,555,654, 7244,577 |
|
||
| 543 | LRRK2 DNA Test | 7,544,786, 7,993,841 |
|
||
| 145 | MAG 'Dual Antigen'® Autoantibody Test | 6,599,756, 6,951,763 |
|
||
| 223 | MFN2 DNA Sequencing Test | 7,727,717, 8,206,922, 8,975,020 |
|
||
| 885 | Monogenic Diabetes (MODY) Evaluation | 5,827,683, 6,187,533, 6,274,310 |
|
||
| 346 | Motor Neuropathy Profile - Complete | 6,599,756 6,951,763 , 5,807,705, 6,020,140 6,077,681, 6,824,999 |
|
||
| 482 | MuSK Antibody Test | 7,267,820, 7,732,147 |
|
||
| 134 | Myelin Protein Zero (MPZ) DNA Sequencing Test | 5,876,927 |
|
||
| 438 | NeoCerebellar Degeneration Paraneoplastic Profile with Recombx | 7,329,499, 5,925,526, 5,807,705, 6,387,639, 7,026,450 |
|
||
| 4620 | NeoComplete Paraneoplastic Profile with Recombx | 7,329,499, 5,925,526, 5,807,705, 6,387,639 7,026,450 |
|
||
| 4722 | NeoEncephalitis Paraneoplastic Profile with Recombx | 7,329,499, 5,807,705, 6,387,639, 7,026,450 |
|
||
| 882 | Neonatal Diabetes Mellitus Evaluation | 6,054,313, 5,863,724 |
|
||
| 360 | NeoSeM® Basic Paraneoplastic Profile | 5,925,526, 5,807,705 |
|
||
| 436 | NeoSensory Neuropathy Paraneoplastic Profile with Recombx™ | 7,329,499, 5,807,705 |
|
||
| 532 | NIPA1 (SPG6) DNA Sequencing Test | 7,332,282, 8,518,638 |
|
||
| 846 | Noonan Syndrome (PTPN11) DNA Sequencing Test | 7,335,469 |
|
||
| 421 | Notch3 DNA Sequencing Test | 7,138,234 |
|
||
| 730 | NPHS1 (Nephrin) Sequencing Analysis | 7,799,529, 7,105,291, 6,207,811 |
|
||
| 710 | NPHS2 (Podocin) Sequencing Analysis | 6,924,110, 7,388,086 |
|
||
| 300 | OPMD DNA Test | 6,828,430, 7,364,852 |
|
||
| 239 | Periaxin DNA Sequencing Test | 7,273,698, 7,537,899 |
|
||
| 889 | Pheochromocytoma Evaluation | 6,312,890, 5759,790 |
|
||
| 728 | PKDx® Familial Mutation Evaluation | 6,656,681, 6,228,591, 6,031,088, 7,294,465, 6,485,960, 6,916,619, 7,273,701, 7,083,915, 7,553,644, 7,521,190, 8,530,161 |
|
||
| 725 | PKDx® Sequencing Analysis | 6,656,681, 6,228,591, 6,031,088, 7,294,465, 6,485,960, 7,553,644, 6,916,619, 7,521,190, 7,273,701, 7,083,915, 7,553,644, 7,521,190, 8,530,161 |
|
||
| 247 | PMP22 DNA Sequencing Test | 5,780,223 |
|
||
| 131 | PMP22 Duplication/Deletion DNA Test | 5,780,223 |
|
||
| 816 | Primary Adrenal Insufficiency Evaluation | 7,217,806, 5,869,039, 7,785,789 |
|
||
| 639 | Primary Dystonia Evaluation | 6,387,616, 6,921,814 |
|
||
| 122 | Recombx™ MaTa Autoantibody Test | 6,387,639, 7,026,450 |
|
||
| 123 | Recombx™ CV2 Antibody Test | 7,329,499, 7,183,400 |
|
||
| 120 | Recombx™ Hu Autoantibody Test | 5,807,705 |
|
||
| 125 | Recombx™ Yo Autoantibody Test | 5,925,526 |
|
||
| 529 | REEP1 (SPG31) DNA Sequencing Test | 7,811,762 |
|
||
| 142 | Rett Syndrome (MECP2) DNA Sequencing Test | 6,709,817, 7,670,773, 8,637,236 |
|
||
| 148 | Rett Syndrome (MECP2) Duplication/Deletion Analysis | 6,709,817, 7,670,773, 8,637,236 |
|
||
| 371 | SCA1 DNA Test | 5,834,183, 5,741,645 |
|
||
| 387 | SCA10 DNA Test | 6,855,497 |
|
||
| 284 | SCA13 Select Exon DNA Test | 7,585,629, 8,163,483 |
|
||
| 593 | SCA14 DNA Test | 7,655,401 |
|
||
| 672 | SCA2 Expansion Analysis | 6,673,535, 6,844,431, 8,957,018 |
|
||
| 105 | SCA3 (Machado-Joseph Disease) DNA Test | 5,840,491 |
|
||
| 675 | SCA5 DNA Sequencing Test | 7,527,931 |
|
||
| 373 | SCA6 DNA Test | 7,329,487 |
|
||
| 677 | SCA7 Expansion Analysis | 6,280,938, 6,514,755, 7,118,893 |
|
||
| 384 | SCA8 DNA Test | 6,524,791, 7,741,458, 8,748,096, 8,247,173 |
|
||
| 537 | SCN1A Deletion Test | 7,723,027, 8,288,096 |
|
||
| 287 | SensoriMotor Neuropathy Profile-Complete | 6,599,756 6,951,763 , 5,807,705, 5,985,578, 6,020,140, 6,824,999 |
|
||
| 265 | Sensory Neuropathy Profile | 6,599,756, 6,951,763 5,807,705, 6,020,140, 5,985,578 |
|
||
| 263 | Sensory Neuropathy Profile-xp | 6,599,756, 6,951,763 , 5,807,705, 6,020,140, 5,985,578 |
|
||
| 594 | SETX DNA Sequencing Test | 7,704,691, 8,192,933 |
|
||
| 214 | SMA Plus (Reflexive) | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
||
| 211 | SMN DNA Sequencing Test | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
||
| 530 | Spastin (SPG4) DNA Sequencing Test | 6,924,126 |
|
||
| 444 | Spinal Muscular Atrophy Carrier Test | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
||
| 111D | Spinal Muscular Atrophy Diagnostic Test | 6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
||
| 210 | Sulfatide Autoantibody Test | 6,020,140, 5,985,578 |
|
||
| 804 | TCF1 (MODY3) DNA Sequencing and Deletion Test | 6,187,533 |
|
||
| 805 | TCF2 (MODY5) DNA Sequencing and Deletion Test | 6,187,533 |
|
||
| 712 | TRPC6 DNA Sequencing Test | 7,745,597 |
|
||
| 523 | TSC Familial Mutation Evaluation | 6,326,483, 6,232,452 |
|
||
| 508 | TSC1 Deletion Analysis | 6,548,258 |
|
||
| 521 | TSC1 DNA Sequencing Test | 6,326,483, 6,548,258 |
|
||
| 524 | TSC2 DNA Deletion Test | 6,232,452 |
|
||
| 522 | TSC2 DNA Sequencing Test | 6,232,452 |
|
||
| 858 | von Hippel Lindau VHL | 5,759,790 |